Literature DB >> 12656897

Differences in biopsy features between prostate cancers located in the transition and peripheral zone.

H Augustin1, A Erbersdobler, M Graefen, T Jaekel, A Haese, H Huland, P G Hammerer.   

Abstract

OBJECTIVE: To identify the zonal location of prostate cancers before surgery, by analysing the mapping of ultrasonography-guided systematic sextant biopsies for differences between cancers located in the transition zone (TZ) and peripheral zone (PZ); and to compare the correlation between Gleason scores of needle biopsies and those of radical prostatectomy (RP) specimens. PATIENTS AND METHODS: In all, 186 patients with TZ (46) and PZ cancers (140) underwent ultrasonography-guided systematic sextant biopsy and RP at the same institution. The clinical and pathological characteristics, and the anatomical location of positive biopsies, were determined and compared using t-tests and chi-square tests. Differences between Gleason scores of needle biopsies and those of RP specimens were evaluated and compared by Cohen kappa testing.
RESULTS: TZ cancers had a significantly lower rate of positive biopsies in the middle (63% vs 80%) and base (50% vs 80%) of the prostate than had PZ cancers. Positive biopsies were exclusively obtained from the apex in 19.6% of TZ and 5% of PZ cancers (P = 0.002). There was exact agreement between Gleason scores of needle biopsies and those of RP specimens in 15.2% of TZ (kappa = 0.02) and 55% of PZ cancers (kappa = 0.25), respectively.
CONCLUSION: Compared with PZ cancers, TZ cancers had a different anatomical pattern of positive biopsies, with lower rates in the middle and base of the prostate. The finding of positive biopsies exclusively in the apex favoured prostate cancer located in the TZ. Furthermore, the correlation between needle biopsy Gleason scores and those of the RP specimens was clearly lower in TZ cancers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12656897     DOI: 10.1046/j.1464-410x.2003.04140.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  6 in total

1.  Incremental value of transition zone and midline apical biopsy at baseline TRUS-guided biopsy for prostate cancer detection.

Authors:  D M Somford; W Vreuls; T S Jansen; J P van Basten; H Vergunst
Journal:  World J Urol       Date:  2013-07-20       Impact factor: 4.226

Review 2.  Prostate zones and cancer: lost in transition?

Authors:  Amin Ali; Alexander Du Feu; Pedro Oliveira; Ananya Choudhury; Robert G Bristow; Esther Baena
Journal:  Nat Rev Urol       Date:  2021-10-19       Impact factor: 14.432

3.  Early channel transurethral resection of the prostate for patients with urinary retention after brachytherapy.

Authors:  You-yun Zhang; Zhi-gen Zhang; Yan-lan Yu; Yi-cheng Chen; Kang-xin Ni; Ming-chao Wang; Wei-ping Zhao; Faisal Rehman; Shaw P Wan; Gong-hui Li
Journal:  J Zhejiang Univ Sci B       Date:  2014-08       Impact factor: 3.066

4.  Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.

Authors:  Dimitra Tsavachidou; Timothy J McDonnell; Sijin Wen; Xuemei Wang; Funda Vakar-Lopez; Louis L Pisters; Curtis A Pettaway; Christopher G Wood; Kim-Anh Do; Peter F Thall; Clifton Stephens; Eleni Efstathiou; Robert Taylor; David G Menter; Patricia Troncoso; Scott M Lippman; Christopher J Logothetis; Jeri Kim
Journal:  J Natl Cancer Inst       Date:  2009-02-24       Impact factor: 13.506

5.  Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings.

Authors:  Laurent Lemaitre; Philippe Puech; Edouard Poncelet; Sébastien Bouyé; Xavier Leroy; Jacques Biserte; Arnauld Villers
Journal:  Eur Radiol       Date:  2008-08-29       Impact factor: 5.315

Review 6.  Extended and saturation needle biopsy for the diagnosis of prostate cancer.

Authors:  Kristin L Chrouser; Michael M Lieber
Journal:  Curr Urol Rep       Date:  2004-06       Impact factor: 2.862

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.